FDA Hits Aesica Over Quality Controls, Record-Keeping Post author:Sam Post published:April 19, 2017 Post category:Drug Industry Daily The FDA has cited contract manufacturer Aesica for quality and record-keeping problems. Source: Drug Industry Daily You Might Also Like FDA Commissioner Califf Tweets About His Priorities February 18, 2022 Gilead’s Lenacapavir Deeply Suppresses HIV Load in Multidrug-Resistant Patients May 15, 2022 PTAB Throws Out Janssen Patent for Prostate Cancer Drug January 18, 2018